Trial of Ixazomib for Kaposi Sarcoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(11 sites)
United States
UC San Diego, San Diego, California Zuckerberg San Francisco General Hospital, San Francisco, California University of Miami Miller School of Medicine, Miami, Florida University of Illinois Cancer Center, Chicago, Illinois Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland Washington University, St Louis, Missouri Mount Sinai Hospital, New York, New York Abramson Cancer Center at Pennsylvania Hospital, Philadelphia, Pennsylvania Thomas Street Clinic, Houston, Texas Thomas Street Clinic, Houston, Texas Virginia Mason Medical Center, Seattle, Washington Last updated February 2026